USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
MYNOSYS CELLULAR DEVICES, INC.
Address:
1061 EASTSHORE HWY. SUITE 201
ALBANY, CA 94710-
Phone:
N/A
URL:
N/A
EIN:
120339156
DUNS:
827036927
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $486,423.00 2
SBIR Phase II $1,553,491.00 1

Award List:

Micro/Nano Devices For Neuroscience Research

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$191,178.00
Agency:
HHS
Principal Investigator:
Christopher Keller
Abstract:
DESCRIPTION (provided by applicant): The long-term objective of Mynosys Cellular Devices is to develop new semi-robotic microdevices that enable scientists to directly physically probe or manipulate individual neurons or subcellular processes for a variet y of experimental and therapeutic purposes.… More

Microtechnology-Enhanced Surgical Device For Pediatric Lens Capsulotomy And Treat

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$295,245.00
Agency:
HHS
Principal Investigator:
Christopher Keller – 510-323-3151
Abstract:
DESCRIPTION (provided by applicant): We propose a new interventional device that solves a significant therapeutic bottleneck in the treatment of lens cataract in children. As the leading cause of childhood blindness, lens cataract interferes with the optical performance of the eye and if untreated,… More

Micro-technology Enhanced Pediatric Lens Capsulotomy Device

Award Year / Program / Phase:
2013 / SBIR / Phase II
Award Amount:
$1,553,491.00
Agency:
HHS
Principal Investigator:
Christopher Keller – 510-323-3151
Abstract:
DESCRIPTION (provided by applicant): We propose an innovative microtechnology-enhanced surgical device that solves a significant therapeutic bottleneck in the treatment of lens cataract in children. As the leading cause of childhood blindness, lens cataract interferes with the optical performance of… More